Drug discovery and formulation development for acute pancreatitis

Area of Science:

• Gastroenterology
• Biomedical Engineering
• Pharmacology

Background:

• Acute pancreatitis presents a sudden, potentially life-threatening inflammatory condition.
• Current traditional drug therapies offer limited efficacy in managing acute pancreatitis.
• Developing effective treatments to address pancreatic microenvironment and prevent multi-organ failure remains a significant challenge.

Purpose of the Study:

• To review the pathogenesis, mechanisms, and severity assessment of acute pancreatitis.
• To discuss traditional Chinese medicine and emerging drug options for acute pancreatitis.
• To summarize advanced drug delivery strategies, particularly bifunctional nanoparticles, for treating acute pancreatitis.

Main Methods:

• Literature review of pathogenesis and mechanisms of acute pancreatitis.
• Analysis of traditional Chinese medicine and novel therapeutic agents.
• Evaluation of drug delivery systems targeting pancreatic inflammatory lesions.
• Focus on bifunctional nanoparticles for combined drug delivery and therapeutic effects.

Main Results:

• Understanding pancreatitis intricacies aids in developing targeted interventions.
• New formulations show promise in delivering therapeutics directly to inflamed pancreatic tissues.
• Bifunctional nanoparticles offer a dual role as carriers and direct therapeutic agents.
• Strategies aim to reduce pancreatic inflammation and prevent disease progression.

Conclusions:

• Enhanced understanding of acute pancreatitis is crucial for improved treatment strategies.
• Novel drug delivery systems, especially bifunctional nanoparticles, represent a promising therapeutic avenue.
• Targeted delivery and dual-action nanoparticles can potentially mitigate pancreatic damage and prevent complications.